APIs are bioactive compounds designed to have specific therapeutic effects on the human and animal body. However, when released into the environment - even in minimal concentrations - they can have harmful effects on ecosystems and the food chain. Additionally, as seen in the production of antifungal drugs, residual APIs in wastewater can contribute to the development of antibiotic resistance in bacteria, representing a serious threat to public health.
To address these challenges, pharmaceutical companies must adopt innovative and efficient wastewater treatment solutions to remove APIs and other micropollutants before water is discharged or reused. However, pharmaceutical wastewater is complex and site-specific. This is why Water Mapping, aligned with ISO 46001 tools, is often recommended before identifying the most suitable treatment train for the production site. This includes characterising the effluent, combined with lab feasibility testing, pilot systems, or rental units. This approach enables the selection of the optimal treatment train for removing APIs from wastewater.
FILL IN THE FORM TO CONTACT OUR EXPERTS
Evaled™ evaporation plants are ideal for wastewater that would otherwise require off-site disposal due to chlorides, APIs, or solvents. Evaled™ can reduce off-site disposal volumes by over 90%, and also produce water that can be reused internally as technical water.
Ozone systems are used to treat wastewater containing residual APIs with poorly biodegradable molecules. Applied either before or after evaporation or biological treatments, ozone ensures further breakdown of APIs or solvents such as H₂S and DMS.
eXeno is a multistage process that leverages specialised microorganisms to degrade APIs and other organic compounds, ensuring high removal efficiency and excellent effluent quality. Ideal for new plants, for upgrading existing systems, or as tertiary post-treatment—especially effective at removing pharmaceuticals, carbon, and nitrogen even during peak loads.
MPPE technology is ideal for separating hydrocarbon solvents from wastewater streams. This system features automatic regeneration of its two vessels, providing continuous treatment without generating gas or residual sludge.
By choosing Veolia for pharmaceutical wastewater treatment, you can benefit from:
Veolia is the ideal partner for pharmaceutical companies seeking innovative, efficient and sustainable solutions for wastewater treatment and API removal. Contact us by filling out the form on top of the page to learn how we can support your environmental compliance and cost-reduction goals.
FILL IN THE FORM TO CONTACT OUR EXPERTSVeolia is committed to protecting and respecting your privacy, and we’ll only use your personal information to administer your account and to provide the products and services you requested from us. From time to time, we would like to contact you about our products and services, as well as other content that may be of interest to you.
You may unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.
By clicking submit, you authorise Veolia to store and process your personal data in order to provide you with the requested content.